L'Oreal Explores Liability Offloading Amid Legal Challenges and Major Deals Reshape Industries
L'Oreal's U.S. subsidiary has enlisted the legal expertise of Weil Gotshal and Ducera to explore options for offloading chemical-related liabilities, particularly those tied to talc-related lawsuits. The move underscores the company's efforts to mitigate ongoing legal challenges in the cosmetics industry.
Berkshire Hathaway has increased its stake in Lennar by $190 million, bringing its total ownership to 12% of the homebuilder. The purchases occurred last Thursday and Friday, following a nearly 7% drop in Lennar's stock on Monday due to a negative report.
New York City lawmakers have scrutinized AI executives and former employees as the city considers implementing guardrails for the industry. Jacob Coxon, a former Anthropic researcher, reiterated his warnings during a hearing on Monday.
KKR has struck a deal to acquire Gen II, a private-capital fund administrator, reflecting the growing trend of investors shifting away from public markets. Meanwhile, Mattel faces mounting pressure from shareholders, including Ariel Investments, which holds a 5.4% stake, to consider a sale due to perceived undervaluation.
The U.S. Supreme Court is deliberating on whether local governments can sue oil companies for climate-related damages, questioning the energy giants' bid to shut down such lawsuits. In another legal development, bondholders of Electronic Arts have alleged a $1.4 billion debt default following the company's largest-ever leveraged buyout.
Texas Attorney General Ken Paxton has launched an investigation into UnitedHealth Group, seeking evidence of potential violations of the Texas Deceptive Trade Practices Act. Additionally, Paramount has announced its leadership team for the combined entity post its $81 billion deal with Warner, with David Ellison and Ynon Kreiz set to lead as co-CEOs.
C.H. Robinson Worldwide has agreed to acquire RXO for approximately $5.8 billion in cash and stock, creating a logistics company with an enterprise value exceeding $25 billion. GE HealthCare is also expanding its medical-imaging business with the acquisition of Sofie for nearly $1 billion, focusing on radiopharmaceuticals.